Target intelligence / Profile preview

Cystatin 13, pseudogene (CST13P)

Target: CST13P
Molecular classification: Other, Pseudogene

Overview

Cystatin 13, pseudogene (CST13P), also known as CTES6, CSTT, and cystatin T, is a pseudogene from the cystatin superfamily in humans[7][8]. Pseudogenes are segments of DNA that resemble functional genes but are generally noncoding and not translated into active proteins. CST13P is not classified as a functional protein, receptor, enzyme, or transporter, and there is no evidence it serves as a direct therapeutic target, is involved in disease mechanisms, or has validated roles in biological pathways[7][8]. While some pseudogenes have regulatory functions, there is no available information supporting an active functional, clinical, or therapeutic role for CST13P.

Other names: CTES6CSTTcystatin T

Beyond the preview

Go deeper on Cystatin 13, pseudogene (CST13P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystatin 13, pseudogene (CST13P).

Explore the full profile